Global Computational Biology Market - Segmented by Application, Tools, Services, End-User and Geography - Growth, Trends and Forecasts (2018 - 2023)

  • ID: 4472847
  • Report
  • Region: Global
  • 120 pages
  • Mordor Intelligence
1 of 5


  • Certara
  • Compugen Ltd
  • Dassault Systemes
  • Genedata AG
  • Insilico Biotechnology AG
  • Leadscope Inc
  • MORE
Computational biology is defined as the application of mathematical models, theoretical methods and computer aided simulation for the study of behavioral, social and biological systems. It is an interdisciplinary field, which includes the principles of applied mathematics, computer science, statistics, genomics, genetics, animation, visualization and a lot more. It makes use of biological data to construct relationship models and algorithms between different biological systems to analyze the differences and similarities among them. The various segments of the industry include computational genomics, computational neuroscience, computational bio-modeling, computational pharmacology, evolutionary biology and cancer research. The global computational biology market is expected to register a CAGR of 19.5% during the forecast period (2018 – 2023).

Increase in Bioinformatics Research

Bioinformatics is the use of IT in biotechnology for the data storage, data warehousing and analyzing the DNA sequences. There are many applications of bioinformatics and its usage has been seen in Microbial genome applications, Molecular medicine, Personalized medicine, Preventative medicine, Gene therapy, Drug development, Antibiotic resistance, Evolutionary studies, Waste cleanup, Biotechnology and many other places. This has led to an increasing research in this field, which further requires the use of computational methods.
Also, increasing number of clinical studies in pharmacogenomics and pharmacokinetics for novel drug development and growth of drug designing, disease modeling and personalized medicine are some other drivers of the market.

Lack of Trained Professionals

Computational biology involves development and application of software, analytical and theoretical methods, mathematical modelling and other computational techniques used for study of biological, behavioral and social systems. This development and application requires use of trained professionals so as to make correct analysis. However, due to the lack of properly trained professionals hampers the market growth.

North America to Dominate the Market

The global computational biology market is segmented by drug type, therapeutic indication and geography. By geography, it is segmented into North America, Europe, Asia-Pacific, the Middle East and Africa and South America.
North America dominates the market due to growing initiatives and investments for R&D of drug discovery, novel drugs, disease modeling, and technological advancements in biological computations.

Key Developments in the Market
  • February 2018: Certara has recently acquired BaseCase, a Life Sciences Data Visualization company.
  • February 2018: Schrödinger launched Cryo-EM Initiative (SCI) to develop breakthrough medicines using cryo-electron microscopy (Cryo-EM) technology.

Reasons to Purchase this Report
  • Market analysis for the global computational biology market, with region-specific assessments and competition analysis on a global and regional scale.
  • Analyzing various perspectives of the industry with the help of Porter’s five forces analysis
  • The treatment type that is expected to dominate the market
  • Regions that are expected to witness fastest growth during the forecast period
  • Identify the latest developments, market shares and strategies employed by the major market players
  • 3-month analyst support along with the Market Estimate sheet (in Excel)
Customization of the Report

This report can be customized to meet your requirements. Please connect with our analyst, who will ensure you get a report that suits your needs.
Note: Product cover images may vary from those shown
2 of 5


  • Certara
  • Compugen Ltd
  • Dassault Systemes
  • Genedata AG
  • Insilico Biotechnology AG
  • Leadscope Inc
  • MORE
1. Introduction
1.1 Market Definition

2. Research Methodology

3. Executive Summary

4. Key Inferences

5. Market Overview
5.1 Current Market Scenario
5.2 Porter's Five Forces
5.2.1 Bargaining Power of Suppliers
5.2.2 Bargaining Power of Consumers
5.2.3 Threats of New Entrants
5.2.4 Threat of Substitute Products and Services
5.2.5 Competitive Rivalry within the Industry

6. Drivers, Restraints, Opportunities And Challenges Analysis (Droc)
6.1 Market Drivers
6.1.1 Increase in Bioinformatics Research
6.1.2 Increasing Number of Clinical Studies in Pharmacogenomics and Pharmacokinetics
6.1.3 Growth of Drug Designing, Disease Modeling, and Personalized Medicine
6.2 Market Restraints
6.2.1 Lack of Trained Professional
6.3 Opportunities
6.4 Key Challenges

7. Market Segmentation
7.1 By Application
7.1.1 Cellular & Biological Simulation Computational Genomics Computational Proteomics Pharmacogenomics Other Cellular and Biological Simulations (Transcriptomics/Metabolomics)
7.1.2 Drug Discovery and Disease Modelling Target Identification Target Validation Lead Discovery Lead Optimization
7.1.3 Preclinical Drug Development Pharmacokinetics Pharmacodynamics
7.1.4 Clinical Trials Phase I Phase II Phase III
7.1.5 Human Body Simulation Software
7.2 By Tools
7.2.1 Databases
7.2.2 Infrastructure(Hardware)
7.2.3 Analysis Software & Services
7.3 By Services
7.3.1 In-House
7.3.2 Contract
7.4 By End - User
7.4.1 Academics
7.4.2 Industry
7.4.3 Commercial
7.5 By Geography
7.5.1 North America United States Canada Mexico
7.5.2 Europe France United Kingdom Germany Italy Spain Rest of Europe
7.5.3 Asia-Pacific India China Japan Australia South Korea Rest of APAC
7.5.4 Middle East & Africa GCC South Africa Rest of Middle East & Africa
7.5.5 South America Brazil Argentina Rest of South America

8. Competitive Landscape
8.1 Mergers And Acquisition Analysis
8.2 Agreements, Collaborations & Partnerships
8.3 New Products Launches

9. Key Players
9.1 Dassault Systemes
9.2 Certara
9.3 Chemical Computing Group Inc.
9.4 Compugen Ltd
9.5 Rosa & Co. LLC (Acquired Entelos)
9.6 Genedata AG
9.7 Insilico Biotechnology AG
9.8 Leadscope Inc
9.9 Nimbus Discovery Llc
9.10 Strand Life Sciences
9.11 Schrodinger
9.12 Simulation Plus Inc

10. Future of the Market
Note: Product cover images may vary from those shown
3 of 5


4 of 5
  • Dassault Systemes
  • Certara
  • Chemical Computing Group Inc.
  • Compugen Ltd
  • Rosa & Co LLC
  • Genedata AG
  • Insilico Biotechnology AG
  • Leadscope Inc
  • Nimbus Discovery LLC
  • Strand Life Sciences
  • Schrodinger
  • Simulation Plus Inc.
Note: Product cover images may vary from those shown
5 of 5
Note: Product cover images may vary from those shown